Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada.
Jacob RA, Zhang A, Ajoge HO, D'Agostino MR, Nirmalarajah K, Shigayeva A, Demian WL, Baker SJC, Derakhshani H, Rossi L, Nasir JA, Panousis EM, Draia AN, Vermeiren C, Gilchrist J, Smieja N, Bulir D, Smieja M, Surette MG, McArthur AG, McGeer AJ, Mubareka S, Banerjee A, Miller MS, Mossman K. Jacob RA, et al. Among authors: shigayeva a. Emerg Infect Dis. 2023 Jul;29(7):1386-1396. doi: 10.3201/eid2907.230198. Epub 2023 Jun 12. Emerg Infect Dis. 2023. PMID: 37308158 Free PMC article.
Patient contact recall after SARS exposure.
Dimoulas P, Green KA, Shigayeva A, Aquino M, McGeer A, Scales DC; Toronto SARS Hospital Investigation Team. Dimoulas P, et al. Among authors: shigayeva a. Emerg Infect Dis. 2005 Apr;11(4):625-8. doi: 10.3201/eid1104.040648. Emerg Infect Dis. 2005. PMID: 15829207 Free PMC article.
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.
Valcourt EJ, Manguiat K, Robinson A, Lin YC, Abe KT, Mubareka S, Shigayeva A, Zhong Z, Girardin RC, DuPuis A, Payne A, McDonough K, Wang Z, Gasser R, Laumaea A, Benlarbi M, Richard J, Prévost J, Anand SP, Dimitrova K, Phillipson C, McGeer A, Gingras AC, Liang C, Petric M, Sekirov I, Morshed M, Finzi A, Drebot M, Wood H. Valcourt EJ, et al. Among authors: shigayeva a. Microbiol Spectr. 2021 Dec 22;9(3):e0088621. doi: 10.1128/Spectrum.00886-21. Epub 2021 Nov 17. Microbiol Spectr. 2021. PMID: 34787495 Free PMC article.
Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance.
Kuster SP, Rudnick W, Shigayeva A, Green K, Baqi M, Gold WL, Lovinsky R, Muller MP, Powis JE, Rau N, Simor AE, Walmsley SL, Low DE, McGeer A; Toronto Invasive Bacterial Diseases Network. Kuster SP, et al. Among authors: shigayeva a. Clin Infect Dis. 2014 Oct;59(7):944-52. doi: 10.1093/cid/ciu497. Epub 2014 Jun 27. Clin Infect Dis. 2014. PMID: 24973312
Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL, Johnstone J, Kitai I, Krajden S, Lovinsky R, Muller M, Powis J, Rau N, Walmsley S, Tyrrell G, Bitnun A, McGeer A; Toronto Invasive Bacterial Diseases Network. Shigayeva A, et al. Clin Infect Dis. 2016 Jan 15;62(2):139-47. doi: 10.1093/cid/civ803. Epub 2015 Sep 9. Clin Infect Dis. 2016. PMID: 26354970
Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada.
Raboud J, Shigayeva A, McGeer A, Bontovics E, Chapman M, Gravel D, Henry B, Lapinsky S, Loeb M, McDonald LC, Ofner M, Paton S, Reynolds D, Scales D, Shen S, Simor A, Stewart T, Vearncombe M, Zoutman D, Green K. Raboud J, et al. Among authors: shigayeva a. PLoS One. 2010 May 19;5(5):e10717. doi: 10.1371/journal.pone.0010717. PLoS One. 2010. PMID: 20502660 Free PMC article.
19 results